Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: A systematic review

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue , 2016, Pages 128-135

  Brownrigg, J R W ^a   Hinchliffe, R J ^a   Apelqvist, J ^b   Boyko, E J ^c   Fitridge, R ^d   Mills, J L ^e   Reekers, J ^f   Shearman, C P ^g   Zierler, R E ^h   Schaper, N C ⁱ  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amputation; Diabetes; Diabetic foot ulcer; Healing; Peripheral artery disease; Prognosis

Indexed keywords

AMPUTATION; ANKLE BRACHIAL INDEX; ANKLE PRESSURE; ARTICLE; DIABETIC FOOT; DISEASE SEVERITY; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; PERFUSION PRESSURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; PRESSURE AND TENSION; PRIORITY JOURNAL; PROGNOSIS; PULSE RATE; RISK ASSESSMENT; SKIN; SKIN PERFUSION PRESSURE; SYSTEMATIC REVIEW; TOE; TOE PRESSURE; TRANSCUTANEOUS OXYGEN MONITORING; ULCER HEALING; ADVERSE EFFECTS; BLOOD FLOW; ENDOVASCULAR SURGERY; EVIDENCE BASED MEDICINE; EXPERIMENTAL THERAPY; FOOT; LIMB SALVAGE; MULTIMODALITY CANCER THERAPY; PERSONALIZED MEDICINE; TRENDS; VASCULARIZATION; WOUND HEALING;

BIOLOGICAL MARKER;

AMPUTATION; BIOMARKERS; COMBINED MODALITY THERAPY; DIABETIC FOOT; ENDOVASCULAR PROCEDURES; EVIDENCE-BASED MEDICINE; FOOT; HUMANS; LIMB SALVAGE; PRECISION MEDICINE; PROGNOSIS; REGIONAL BLOOD FLOW; RISK ASSESSMENT; SKIN; THERAPIES, INVESTIGATIONAL; WOUND HEALING;

EID: 84956825369     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2704     Document Type: Article

References (34)

1. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50(1): 18-25.
2. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 2008; 51: 747-55.
3. Siersma V, Thorsen H, Holstein PE, et al. Importance of factors determining the low health-related quality of life in people presenting with a diabetic foot ulcer: the Eurodiale study. Diabet Med 2013; 30: 1382-7.
4. Brand FN, Kannel WB, Evans J, Larson MG, Wolf PA. Glucose intolerance, physical signs of peripheral arterial disease, and risk of cardiovascular events: the Framingham study. Am Heart J 1998; 136: 919-927.
5. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114: 688-699.
6. Karthikesalingam A, Holt PJE, Moxey P, Jones KG, Thompson MM, Hinchliffe RJ. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med 2010; 27: 544-549.
7. Meggitt B. Surgical management of the diabetic foot. Br J Hosp Med 1976; 16: 227-232.
8. Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981; 2: 64-122.
9. Beckert S, Pietsch AM, Kuper M, et al. M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds. Ann Surg 2009; 249: 677-681.
10. Beckert S, Witte M, Wicke C, Konigsrainer A, Coerper S. A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1000 patients. Diabetes Care 2006; 29: 988-992.
11. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996; 35: 528-531.
12. Faglia E, Favales F, Quarantiello A, et al. Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers. Diabetes Care 1998; 21: 625-630.
13. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24: 1433-1437.
14. De Vivo S, Palmer-Kazen U, Kalin B, Wahlberg E. Risk factors for poor collateral development in claudication. Vasc Endovascular Surg 2005; 39: 519-524.
15. Moher D, Liberati A, Tetzlaff J. Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
16. Hinchliffe RJ, Andros G, Apelqvist J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diab Metab Res Reviews 2012; 28(S1): 179-217.
17. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006 Mar 21; 144(6): 427-37.
18. Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med 2013 Feb 19; 158(4): 280-6.
19. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005; 365: 1500-05.
20. Jaeschke R, Guyatt GH. Sackett DL for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. VI. How to use an article about a diagnostic test. B: What are the results and will they help me in caring for my patients? JAMA 1994; 271: 703-7.
21. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001; 323: 157-62.
22. Apelqvist J, Elgzyri T, Larsson J, Londahl M, Nyberg P, Thorne J. Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J Vasc Surg 2011; 53: 1582-8.
23. Elgzyri T, Larsson J, Nyberg P, Thorne J, Eriksson KF, Apelqvist J. Early revascularization after admittance to a diabetic foot centre affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg 2014.
24. Elgzyri T, Larsson J, Thorne J, Eriksson KF, Apelqvist J. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg
25. 2 as an accurate predictor of therapy in limb salvage. Ann Vasc Surg 1996; 10: 224-227.
26. Holstein P, Lassen NA. Healing of ulcers on the feet correlated with distal blood pressure measurements in occlusive arterial disease. Acta Orthop Scand 1980; 51: 995-1006.
27. Wallin L, Bjornsson H, Stenstrom A. Fluroescein angiography for predicting healing of foot ulcers. Acta Orthop Scand 1989; 60: 40-44.
28. Tsai CY, Chu SY, Wen YW, et al. The value of Doppler waveform analysis in predicting major low extremity amputation among dialysis patients treated for diabetic foot ulcers. Diabetes Res Clin Pract 2013; 100: 181-188.
29. Kalani M, Ostergren J, Brismar K, Jorneskog G, Fagrell B. Transcutaneous oxygen tension and toe pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care 1999; 22: 147-151.
30. Brechow A, Slesaczeck T, Munch D, et al. Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease. Ther Adv Endocrinol Metabol 2013; 4: 83-94.
31. Gershater MA, Londahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009; 52: 398-407.
32. Faris I, Duncan H. Skin perfusion pressure in the prediction of healing in diabetic patients with ulcers or gangrene of the foot. J Vasc Surg 1985; 2: 536-40.
33. McGee S. Simplifying likelihood ratios. J Gen Intern Med 2002; 17: 647-650.
34. Schaper NC, Andros G, Apelqvist J, et al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011. Diabetes Metab Res Rev 2012; 28: 236-237.